Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,834 shares of the company’s stock after selling 447 shares during the quarter. Yousif Capital Management LLC’s holdings in Henry Schein were worth $1,442,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the company. Cromwell Holdings LLC boosted its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Versant Capital Management Inc lifted its holdings in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares during the last quarter. City State Bank acquired a new position in Henry Schein in the fourth quarter valued at approximately $55,000. Farther Finance Advisors LLC grew its position in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the period. Finally, Mather Group LLC. increased its stake in Henry Schein by 43.7% during the fourth quarter. Mather Group LLC. now owns 1,503 shares of the company’s stock worth $104,000 after acquiring an additional 457 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 0.4 %

Shares of NASDAQ:HSIC opened at $77.20 on Thursday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The firm’s 50 day moving average price is $73.85 and its 200 day moving average price is $71.93. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.63 billion, a price-to-earnings ratio of 31.77, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HSIC. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Barrington Research upped their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, January 30th. Finally, Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and a consensus target price of $80.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.